Camp4 Therapeutics director granted 28,000 options
Camp4 Therapeutics director Steven H. Holtzman received a grant of stock options for 28,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Camp4 Therapeutics director Steven H. Holtzman received a grant of stock options for 28,000 shares of common stock. The options have an exercise price of $4.34 per share and expire on June 9, 2036. All 28,000 options vest on the earlier of the first anniversary of the grant date or the company’s next annual stockholder meeting, as long as he continues serving the company through that date.
Insider Trade Summary
Grant/Award: 28,000 shares
Grant/Award
1 txn
Insider
Holtzman Steven H
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 28,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 28,000 contracts (Direct)
Footnotes (1)
- F1. The shares underlying the option vest in their entirety on the earlier of the first anniversary of the grant date or the date of the issuer's next annual meeting of stockholders, subject to continued service to the Company through the applicable vesting date.
Key Figures
Options granted: 28,000 options
Exercise price: $4.34 per share
Expiration date: June 9, 2036
+2 more
5 metrics
Options granted
28,000 options
Grant to director Steven H. Holtzman
Exercise price
$4.34 per share
Stock option strike price
Expiration date
June 9, 2036
Option term end
Shares underlying options
28,000 shares
Common stock underlying the derivative
Post-grant derivative holdings
28,000 options
Total options held following transaction
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, Common Stock, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "4.3400""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-06-09T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
vest in their entirety financial
"The shares underlying the option vest in their entirety on the earlier..."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Camp4 Therapeutics (CAMP) report in this Form 4 filing?
Camp4 Therapeutics reported that director Steven H. Holtzman received a grant of stock options for 28,000 shares of common stock. These options are part of his compensation and give him the right to buy shares at a fixed exercise price.
How many Camp4 Therapeutics (CAMP) options were granted to Steven H. Holtzman?
Steven H. Holtzman was granted stock options covering 28,000 shares of Camp4 Therapeutics common stock. This grant increases his derivative holdings and reflects equity-based compensation tied to the company’s future share performance.
What is the exercise price of the new Camp4 Therapeutics (CAMP) options?
The newly granted Camp4 Therapeutics stock options have an exercise price of $4.34 per share. This means Holtzman can buy company shares at $4.34 once the options vest and before they expire, potentially benefiting if the market price rises.
When do Steven H. Holtzman’s Camp4 Therapeutics (CAMP) options vest?
The 28,000 options vest in full on the earlier of the first anniversary of the grant date or the company’s next annual meeting of stockholders. Vesting is conditioned on Holtzman’s continued service with Camp4 Therapeutics through the applicable vesting date.
When do the newly granted Camp4 Therapeutics (CAMP) options expire?
The granted stock options expire on June 9, 2036, if not exercised earlier. After that expiration date, Holtzman will no longer be able to buy Camp4 Therapeutics shares under this specific option grant, even if the options had vested previously.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates